Unexpected Flow Cytometric Results with two Small GPIIb/IIIa Blockers: Eptifibatide and Tirofiban

Thromb Haemost 2001; 85(03): 561-562
DOI: 10.1055/s-0037-1615624

Letters to the Editor

Schattauer GmbH

Nathalie Hézard

¹Laboratoire Central d’Hématologie

,

Damien Metz

²Service de Cardiologie, CHU Robert Debré, Reims, France

,

Sophie Tassan-Mangina

²Service de Cardiologie, CHU Robert Debré, Reims, France

,

Gérard Potron

¹Laboratoire Central d’Hématologie

,

Philippe Nguyên

¹Laboratoire Central d’Hématologie

References
1 Hézard N, Metz D, Nazeyrollas P, Nguyen P, Simon G, Daliphard S, Droulle C, Elaerts J, Potron G. Free and total platelet glycoprotein IIb/IIIa measurement in whole blood by quantitative flow cytometry during and after infusion of c7E3 Fab in patients undergoing PTCA. Thromb Haemost 1999; 81: 869-73.
2 Hézard N, Metz D, Nazeyrollas P, Droulle C, Elaerts J, Potron G, Nguyen P. Use of PFA-100™ apparatus to assess platelet function in patients undergoing PTCA during and after infusion of c7E3 Fab in the presence of other antiplatelet agents. Thromb Haemost 2000; 83: 540-4.
3 Quinn M, Deering A, Stewart M, Cox D, Foley B, Fitzgerald D. Quantifying GPIIb/IIIa receptor binding using 2 monoclonal antibodies. Discriminating abciximab and small molecular weight antagonists. Circulation 1999; 99: 2231-8.
4 Topol EJ, Byzova TV, Plow EF. Platelet GPIIb/IIIa blockers. Lancet 1999; 353: 22731.